Stock listing

Lang & Schwarz:923818 United Therapeutics Corporation Aktie

German listing (Lang & Schwarz) of United Therapeutics Corporation · home listing NASDAQ:UTHR

Follow United Therapeutics Corporation into a list and get an email when it puts out news.

Home listing price · NASDAQ:UTHR

$533.12 USD -8.39 (-1.5%)

Close on Oct 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:UTHR

Since Jul 6, 2026 -2.6% · daily closes, Jul 6, 2026 – Oct 16, 2026, adjusted for splits
Day range
$530.18 – $551.77 USDOct 16, 2026
Volume
654,280 sharesOct 16, 2026
Market value
$22.87B USDAt the close on Oct 16, 2026 · price × 42.89M shares outstanding
United Therapeutics Corporation logo
Ticker
Lang & Schwarz:923818
Asset type
Stock
Exchange
Lang & Schwarz
Currency
EUR

What changed lately

Calls

Replays

  • United Therapeutics (NASDAQ:UTHR) Q2 2026 Earnings Call

    Wed, Aug 05, 2026 · 9:00 AM ET

    Watch Transcript
  • United Therapeutics (NASDAQ:UTHR) Q1 2026 Earnings Call

    Wed, May 06, 2026 · 9:00 AM ET

    Watch Transcript
  • United Therapeutics (NASDAQ:UTHR) Q4 2025 Earnings Call

    Wed, Feb 25, 2026 · 9:00 AM ET

    Watch Transcript

Latest news

All United Therapeutics Corporation news

Decks

United Therapeutics Corporation on 6ix

News releases
44 in the last 12 months · 221 in all · newest Oct 19, 2026 · oldest 2019
Calls
22 calls with a replay · 22 with a transcript · latest Aug 5, 2026
Decks
22 decks · latest Aug 5, 2026

Where United Therapeutics Corporation is listed

ListingExchangeCountryCurrency
NASDAQ:UTHR · Home listingNASDAQUnited StatesUSD
gettex:UTHgettexGermanyEUR
LS Exchange:923818LS ExchangeGermanyEUR
Lang & Schwarz:923818 · This pageLang & SchwarzGermanyEUR
BMV:UTHRBMVMexicoMXN
Tradegate:UTHTradegateGermanyEUR
B3:U2TH34B3BrazilBRL
Frankfurt:UTHFrankfurtGermanyEUR
Munich:UTHMunichGermanyEUR
BIVA:UTHRBIVAMexicoMXN
BOATS:UTHRBOATSUnited StatesUSD
BX Swiss:UTHBX SwissSwitzerlandCHF
Dusseldorf:UTHDusseldorfGermanyEUR
Stuttgart:UTHStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about United Therapeutics Corporation.